Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3227
Title: How low can we go? The implications of low bacterial load in respiratory microbiota studies
Authors: Nelson, M. T.
Leach, A. J.
Marsh, R. L.
Pope, C. E.
Smith-Vaughan, H. C.
Chang, Anne 
Hoffman, L. R.
Issue Date: 2018
Source: 10 , 2018, p. 7
Pages: 7
Journal: Pneumonia (Nathan)
Abstract: BACKGROUND: Culture-independent sequencing methods are increasingly used to investigate the microbiota associated with human mucosal surfaces, including sites that have low bacterial load in healthy individuals (e.g. the lungs). Standard microbiota methods developed for analysis of high bacterial load specimens (e.g. stool) may require modification when bacterial load is low, as background contamination derived from sterile laboratory reagents and kits can dominate sequence data when few bacteria are present. MAIN BODY: Bacterial load in respiratory specimens may vary depending on the specimen type, specimen volume, the anatomic site sampled and clinical parameters. This review discusses methodological issues inherent to analysis of low bacterial load specimens and recommends strategies for successful respiratory microbiota studies. The range of methods currently used to process DNA from low bacterial load specimens, and the strategies used to identify and exclude background contamination are also discussed. CONCLUSION: Microbiota studies that include low bacterial load specimens require additional tests to ensure that background contamination does not bias the results or interpretation. Several methods are currently used to analyse the microbiota in low bacterial load respiratory specimens; however, there is scant literature comparing the effectiveness and biases of different methods. Further research is needed to define optimal methods for analysing the microbiota in low bacterial load specimens.2200-6133Marsh, Robyn L
Nelson, Maria T
Pope, Chris E
Leach, Amanda J
Hoffman, Lucas R
Chang, Anne B
Smith-Vaughan, Heidi C
P30 DK089507/DK/NIDDK NIH HHS/United States
R01 NS095979/NS/NINDS NIH HHS/United States
R01 DK095869/DK/NIDDK NIH HHS/United States
T32 AI055396/AI/NIAID NIH HHS/United States
T32 GM007266/GM/NIGMS NIH HHS/United States
Journal Article
Review
Pneumonia (Nathan). 2018 Jul 5;10:7. doi: 10.1186/s41479-018-0051-8. eCollection 2018.
DOI: 10.1186/s41479-018-0051-8
Keywords: this article. As Director of the Center for Cystic Fibrosis Microbiology, LRH;provides consultation for private and academic entities designing studies of new;respiratory therapies. All other authors declare they have no competing;interests.Springer Nature remains neutral with regard to jurisdictional claims in;Bacterial load;16S rRNA gene sequencingBackground contamination;published maps and institutional affiliations.;Low bacterial load;Microbiota;investigator-initiated studies from Novartis and Vertex on topics described in
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

76
checked on Mar 25, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.